Endocrine disrupting chemicals in Hungarian canned foods

Por Yamamoto, Masaharu, Láng, István, Sakai, Hiroshi, Nakadaira, Hiroto, Nakamura, Kazutoshi, Tsuchiya, Yasuo, Tsugane, Shoichiro
Publicado em 2002

A Comparative Analysis on the Efficacy and Safety of Intaxel® and Taxol® in Advanced Metastatic Breast Cancer

Por Lang, Istvan, Rubovszky, Gabor, Horvath, Zsolt, Ganofszky, Erna, Szabo, Eszter, Dank, Magdolna, Boer, Katalin, Hitre, Erika
Publicado em 2013

Progress on BIG 1-02/IBCSG 27-02/ NSABP B-37, A Prospective Randomized Trial of Evaluating Chemotherapy after Local Therapy for Isolated Locoregional Recurrences of Breast Cancer

Por Wapnir, Irene L., Aebi, Stefan, Gelber, Shari, Anderson, Stewart J., Láng, István, Robidoux, André, Mamounas, Eleftherios P., Wolmark, Norman
Publicado em 2008

Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu– positive advanced breast cancer: results...

Por Thallinger, Christiane, Lang, Istvan, Kuhar, Cvetka Grasic, Bartsch, Rupert, Singer, Christian F., Petruzelka, Lubos, Melichar, Bohuslav, Knittelfelder, Regina, Brodowicz, Thomas, Zielinski, Christoph
Publicado no BMC Cancer (2016)

Predictive role of hand–foot syndrome in patients receiving first-line capecitabine plus bevacizumab for HER2-negative metastatic breast cancer

Por Zielinski, Christoph, Lang, Istvan, Beslija, Semir, Kahan, Zsuzsanna, Inbar, Moshe J, Stemmer, Salomon M, Anghel, Rodica, Vrbanec, Damir, Messinger, Diethelm, Brodowicz, Thomas
Publicado no Br J Cancer (2016)

Serum estrone concentration, estrone sulfate/estrone ratio and BMI are associated with human epidermal growth factor receptor 2 and progesterone receptor status in postmenopausal p...

Por Vincze, Borbála, Kapuvári, Bence, Udvarhelyi, Nóra, Horváth, Zsolt, Mátrai, Zoltán, Czeyda-Pommersheim, Ferenc, Kőhalmy, Krisztina, Kovács, Judit, Boldizsár, Mariann, Láng, István, Kásler, Miklós
Publicado no Springerplus (2015)

Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary

Por Nagahashi, Masayuki, Ajioka, Yoichi, Lang, Istvan, Szentirmay, Zoltan, Kasler, Miklos, Nakadaira, Hiroto, Yokoyama, Naoyuki, Watanabe, Gen, Nishikura, Ken, Wakai, Toshifumi, Shirai, Yoshio, Hatakeyama, Katsuyoshi, Yamamoto, Masaharu
Publicado em 2008

Bosutinib in Combination With the Aromatase Inhibitor Letrozole: A Phase II Trial in Postmenopausal Women Evaluating First-Line Endocrine Therapy in Locally Advanced or Metastatic...

Por Moy, Beverly, Neven, Patrick, Lebrun, Fabienne, Bellet, Meritxell, Xu, Binghe, Sarosiek, Tomasz, Chow, Louis, Goss, Paul, Zacharchuk, Charles, Leip, Eric, Turnbull, Kathleen, Bardy-Bouxin, Nathalie, Duvillié, Ladan, Láng, István
Publicado em 2014

Bosutinib in Combination With the Aromatase Inhibitor Exemestane: A Phase II Trial in Postmenopausal Women With Previously Treated Locally Advanced or Metastatic Hormone Receptor-P...

Por Moy, Beverly, Neven, Patrick, Lebrun, Fabienne, Bellet, Meritxell, Xu, Binghe, Sarosiek, Tomasz, Chow, Louis, Goss, Paul, Zacharchuk, Charles, Leip, Eric, Turnbull, Kathleen, Bardy-Bouxin, Nathalie, Duvillié, Ladan, Láng, István
Publicado em 2014

Evaluating Letrozole and Tamoxifen Alone and in Sequence for Postmenopausal Women with Steroid Hormone Receptor-Positive Breast Cancer: the BIG 1-98 Randomized Clinical Trial at 8....

Por Regan, Meredith M., Neven, Patrick, Giobbie-Hurder, Anita, Goldhirsch, Aron, Ejlertsen, Bent, Mauriac, Louis, Forbes, John F., Smith, Ian, Láng, István, Wardley, Andrew, Rabaglio, Manuela, Price, Karen N., Gelber, Richard D., Coates, Alan S., Thürlimann, Beat
Publicado em 2011

Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence

Por Chirgwin, Jacquie H., Giobbie-Hurder, Anita, Coates, Alan S., Price, Karen N., Ejlertsen, Bent, Debled, Marc, Gelber, Richard D., Goldhirsch, Aron, Smith, Ian, Rabaglio, Manuela, Forbes, John F., Neven, Patrick, Láng, István, Colleoni, Marco, Thürlimann, Beat
Publicado no J Clin Oncol (2016)

Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from...

Por Finn, Richard S., Crown, John P., Ettl, Johannes, Schmidt, Marcus, Bondarenko, Igor M., Lang, Istvan, Pinter, Tamas, Boer, Katalin, Patel, Ravindranath, Randolph, Sophia, Kim, Sindy T., Huang, Xin, Schnell, Patrick, Nadanaciva, Sashi, Bartlett, Cynthia Huang, Slamon, Dennis J.
Publicado no Breast Cancer Res (2016)

Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: TEXT...

Por Regan, Meredith M., Francis, Prudence A., Pagani, Olivia, Fleming, Gini F., Walley, Barbara A., Viale, Giuseppe, Colleoni, Marco, Láng, István, Gómez, Henry L., Tondini, Carlo, Pinotti, Graziella, Price, Karen N., Coates, Alan S., Goldhirsch, Aron, Gelber, Richard D.
Publicado no J Clin Oncol (2016)

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-0...

Por Pruneri, Giancarlo, Gray, Kathryn P., Vingiani, Andrea, Viale, Giuseppe, Curigliano, Giuseppe, Criscitiello, Carmen, Láng, István, Ruhstaller, Thomas, Gianni, Lorenzo, Goldhirsch, Aron, Kammler, Roswitha, Price, Karen N., Cancello, Giuseppe, Munzone, Elisabetta, Gelber, Richard D., Regan, Meredith M., Colleoni, Marco
Publicado no Breast Cancer Res Treat (2016)

Analyses Adjusting for Selective Crossover Show Improved Overall Survival With Adjuvant Letrozole Compared With Tamoxifen in the BIG 1-98 Study

Por Colleoni, Marco, Giobbie-Hurder, Anita, Regan, Meredith M., Thürlimann, Beat, Mouridsen, Henning, Mauriac, Louis, Forbes, John F., Paridaens, Robert, Láng, István, Smith, Ian, Chirgwin, Jacquie, Pienkowski, Tadeusz, Wardley, Andrew, Price, Karen N., Gelber, Richard D., Coates, Alan S., Goldhirsch, Aron
Publicado em 2011

Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial

Por Ewertz, Marianne, Gray, Kathryn P., Regan, Meredith M., Ejlertsen, Bent, Price, Karen N., Thürlimann, Beat, Bonnefoi, Hervé, Forbes, John F., Paridaens, Robert J., Rabaglio, Manuela, Gelber, Richard D., Colleoni, Marco, Láng, István, Smith, Ian E., Coates, Alan S., Goldhirsch, Aron, Mouridsen, Henning T.
Publicado em 2012

Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a “standard chemotherapy regimen”: the CASA randomized...

Por Crivellari, Diana, Gray, Kathryn P, Dellapasqua, Silvia, Puglisi, Fabio, Ribi, Karin, Price, Karen N, Láng, István, Gianni, Lorenzo, Spazzapan, Simon, Pinotti, Graziella, Lüthi, Jean-Marc, Gelber, Richard D, Regan, Meredith M, Colleoni, Marco, Castiglione-Gertsch, Monica, Maibach, Rudolf, Rabaglio, Manuela, Coates, Alan S, Goldhirsch, Aron
Publicado em 2013

Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial

Por Sonnenblick, Amir, de Azambuja, Evandro, Agbor-tarh, Dominique, Bradbury, Ian, Campbell, Christine, Huang, Yingjie, Dueck, Amylou C., Pritchard, Kathleen I., Wolff, Antonio C., Jackisch, Christian, Lang, Istvan, Untch, Michael, Smith, Ian, Boyle, Frances, Xu, Binghe, Gomez, Henry, Perez, Edith A., Piccart, Martine, Azim, Hatem A.
Publicado no J Natl Cancer Inst (2016)

Poor Prognosis after Second Locoregional Recurrences in the CALOR Trial

Por Wapnir, Irene L., Gelber, Shari, Anderson, Stewart J., Mamounas, Eleftherios P., Robidoux, André, Martín, Miguel, Nortier, Johan W.R., Geyer, Charles E., Paterson, Alexander H.G., Láng, István, Price, Karen N., Coates, Alan S., Gelber, Richard D., Rastogi, Priya, Regan, Meredith M., Wolmark, Norman, Aebi, Stefan
Publicado no Ann Surg Oncol (2016)

Analysis of Regional Timelines To Set Up a Global Phase III Clinical Trial in Breast Cancer: The Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Experience

Por Metzger-Filho, Otto, de Azambuja, Evandro, Bradbury, Ian, Saini, Kamal S., Bines, José, Simon, Sergio D., Dooren, Veerle Van, Aktan, Gursel, Pritchard, Kathleen I., Wolff, Antonio C., Smith, Ian, Jackisch, Christian, Lang, Istvan, Untch, Michael, Boyle, Frances, Xu, Binghe, Baselga, Jose, Perez, Edith A., Piccart-Gebhart, Martine
Publicado em 2013